Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: ROCHE DIAGNOSTICS CORPORATION
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2022-10-01 to 2025-09-30
Current total value of award: $1449435.99
Description: CLINICAL CHEMISTRY AND IMMUNOASSAYS REAGENTS: MOD P00014 - INCORPORATE FY25 FUNDS AND ACWS TRANSITION INFORMATION.